Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gsk Plc ADR (GSK)

Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,790,552
  • Shares Outstanding, K 2,072,482
  • Annual Sales, $ 37,725 M
  • Annual Income, $ 6,130 M
  • 60-Month Beta 0.66
  • Price/Sales 2.12
  • Price/Cash Flow 7.78
  • Price/Book 4.98
Trade GSK with:

Options Overview Details

View History
  • Implied Volatility 21.46% ( -9.45%)
  • Historical Volatility 31.22%
  • IV Percentile 71%
  • IV Rank 51.06%
  • IV High 30.91% on 06/27/24
  • IV Low 11.60% on 03/11/24
  • Put/Call Vol Ratio 0.68
  • Today's Volume 3,945
  • Volume Avg (30-Day) 6,020
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 88,314
  • Open Int (30-Day) 118,169

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.99
  • Number of Estimates 4
  • High Estimate 1.02
  • Low Estimate 0.96
  • Prior Year 0.97
  • Growth Rate Est. (year over year) +2.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.20 +0.79%
on 06/27/24
45.01 -14.46%
on 05/31/24
-5.74 (-12.97%)
since 05/28/24
3-Month
38.20 +0.79%
on 06/27/24
45.92 -16.17%
on 05/15/24
-4.37 (-10.19%)
since 03/28/24
52-Week
33.67 +14.33%
on 11/02/23
45.92 -16.17%
on 05/15/24
+2.97 (+8.36%)
since 06/28/23

Most Recent Stories

More News
Cancer Rates Surge: Key Biotech Stocks Leading the Charge in Oncology Drug Development

USA News Group News Commentary – According to the American Cancer Society, 2024 will be the first year the USA expects to have more than 2 million new cancer cases. In order to respond to the rising...

ONCY : 0.9900 (-1.98%)
ONC.TO : 1.35 (-2.17%)
GSK : 38.50 (-0.36%)
GH : 28.88 (-0.59%)
EXEL : 22.47 (-0.27%)
GILD : 68.61 (-0.32%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.9900 (-1.98%)
ONC.TO : 1.35 (-2.17%)
GOVX : 3.18 (-10.28%)
GSK : 38.50 (-0.36%)
AZN : 77.99 (-0.24%)
MRK : 123.80 (-4.64%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

ONCY : 0.9900 (-1.98%)
ONC.TO : 1.35 (-2.17%)
GOVX : 3.18 (-10.28%)
GSK : 38.50 (-0.36%)
AZN : 77.99 (-0.24%)
MRK : 123.80 (-4.64%)
Is Moderna Stock a Buy Now That It's a 2-Product Company?

The Food and Drug Administration recently approved a new vaccine from Moderna, but the stock dipped in response.

PFE : 27.98 (+0.65%)
GSK : 38.50 (-0.36%)
MRNA : 118.75 (-2.01%)
Option Volatility And Earnings Report For May 13- 17

Earnings season is slowing down, but we still have a few big names reporting. This week, we have Alibaba, Home Depot, Walmart, Cisco and Deere & Company all reporting.

BABA : 72.00 (-0.51%)
HD : 344.24 (+0.81%)
WMT : 67.71 (-0.25%)
CSCO : 47.51 (+0.13%)
DE : 373.63 (-0.45%)
COIN : 222.23 (-0.79%)
RIOT : 9.14 (+0.22%)
GSK : 38.50 (-0.36%)
ZM : 59.19 (+1.23%)
CCJ : 49.20 (-4.95%)
TSLA : 197.88 (+0.23%)
CHWY : 27.24 (-6.23%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 12,356.000 (+0.23%)
AZN : 77.99 (-0.24%)
GSK.LN : 1,529.500 (+0.23%)
GSK : 38.50 (-0.36%)
Down 75%. Is Agenus Stock a Buy on the Dip?

Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.

RILY : 17.64 (+2.02%)
MRK : 123.80 (-4.64%)
BMY : 41.53 (+0.05%)
GSK : 38.50 (-0.36%)
AGEN : 16.75 (+18.63%)
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

These stocks could rocket higher, but they also present significant risks.

BMY : 41.53 (+0.05%)
GSK : 38.50 (-0.36%)
RILY : 17.64 (+2.02%)
DNA : 0.3343 (+8.12%)
AGEN : 16.75 (+18.63%)
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.

ME : 0.3912 (-7.58%)
GSK : 38.50 (-0.36%)
Find Therapeutics Announces Appointment of Dr. Anthony Johnson to its Board of Directors

/CNW/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced that...

GSK : 38.50 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 39.45
2nd Resistance Point 39.24
1st Resistance Point 38.87
Last Price 38.50
1st Support Level 38.29
2nd Support Level 38.08
3rd Support Level 37.71

See More

52-Week High 45.92
Fibonacci 61.8% 41.25
Fibonacci 50% 39.80
Last Price 38.50
Fibonacci 38.2% 38.35
52-Week Low 33.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar